QNTA grabbed some down here was .20 earlier in the week. announced that it has filed its final set of data requested by the US Food and Drug Administration (FDA) for its Pre-Investigational New Drug (PIND #150335) filing on its lead drug candidate Escozine:registered: as a COVID-19 therapeutic. Along with the submission of a batch of Escozine:registered: previously announced specifically produced for the FDA, the Company believes that this will be the last submission necessary in order to receive IND designation from the regulatory body in the United States.

https://www.globenewswire.com/news-release/20...idate.html